(Q82657711)

English

Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above

scientific article published on 29 November 2010

Statements

Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit